#news #biotech New insight into KRAS mutations may improve cancer drug development

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New insight into KRAS mutations may improve cancer drug development .KRAS is a common oncogene often found in cancers of the pancreas, colon and lung, but drugs targeting it remain elusive. A new study provides some clarity for future drug development efforts with its finding that the effects of different KRAS mutations are much more complicated than scientists initially believed.

from FierceBiotech: Biotech https://ift.tt/2QqJwjZ